Structural rearrangements as a recurrent pathogenic mechanism for SETBP1 haploinsufficiency

被引:1
|
作者
Alesi, V. [1 ]
Genovese, S. [1 ]
Roberti, M. C. [1 ]
Sallicandro, E. [1 ]
Di Tommaso, S. [1 ]
Loddo, S. [1 ]
Orlando, V. [1 ]
Pompili, D. [1 ]
Calacci, C. [1 ]
Mei, V. [1 ]
Pisaneschi, E. [1 ]
Faggiano, M. V. [1 ]
Morgia, A. [1 ]
Mammi, C. [2 ]
Astrea, G. [3 ]
Battini, R. [3 ,4 ]
Priolo, M. [2 ]
Dentici, M. L. [5 ]
Milone, R. [3 ]
Novelli, A. [1 ]
机构
[1] IRCCS, Bambino Gesu Children Hosp, Translat Cytogen Res Unit, Lab Med Genet, I-00165 Rome, Italy
[2] Great Metropolitan Hosp Reggio Calabria, Operat Unit Med Genet, I-89100 Reggio Di Calabria, Italy
[3] IRCCS Fdn Stella Maris, Dept Dev Neurosci, I-56125 Pisa, Italy
[4] Univ Pisa, Dept Clin & Expt Med, I-56100 Pisa, Italy
[5] IRCCS, Bambino Gesu Children Hosp, Med Genet Unit, I-00146 Rome, Italy
关键词
SETBP1; Optical genome mapping; OGM; Complex rearrangement; Translocation; RASopathy; CHROMOSOME REARRANGEMENTS; LANGUAGE; SPEECH;
D O I
10.1186/s40246-024-00600-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chromosomal structural rearrangements consist of anomalies in genomic architecture that may or may not be associated with genetic material gain and loss. Evaluating the precise breakpoint is crucial from a diagnostic point of view, highlighting possible gene disruption and addressing to appropriate genotype-phenotype association. Structural rearrangements can either occur randomly within the genome or present with a recurrence, mainly due to peculiar genomic features of the surrounding regions. We report about three non-related individuals, harboring chromosomal structural rearrangements interrupting SETBP1, leading to gene haploinsufficiency. Two out of them resulted negative to Chromosomal Microarray Analysis (CMA), being the rearrangement balanced at a microarray resolution. The third one, presenting with a complex three-chromosome rearrangement, had been previously diagnosed with SETBP1 haploinsufficiency due to a partial gene deletion at one of the chromosomal breakpoints. We thoroughly characterized the rearrangements by means of Optical Genome Mapping (OGM) and Whole Genome Sequencing (WGS), providing details about the involved sequences and the underlying mechanisms. We propose structural variants as a recurrent event in SETBP1 haploinsufficiency, which may be overlooked by laboratory routine genomic analyses (CMA and Whole Exome Sequencing) or only partially determined when associated with genomic losses at breakpoints. We finally introduce a possible role of SETBP1 in a Noonan-like phenotype.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Speech, language and communication phenotyping in rare genetic syndromes: Commentary on Speech and language deficits are central to SETBP1 haploinsufficiency disorder
    Freeth, Megan
    Al-Jawahiri, Reem
    Smith, Harriet
    Stokes, Louis
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2021, 29 (08) : 1166 - 1167
  • [32] Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
    Fernandez-Mercado, Marta
    Pellagatti, Andrea
    Di Genua, Cristina
    Jose Larrayoz, Maria
    Winkelmann, Nils
    Aranaz, Paula
    Burns, Adam
    Schuh, Anna
    Jose Calasanz, Maria
    Cross, Nicholas C. P.
    Boultwood, Jacqueline
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (02) : 235 - 239
  • [33] SETBP1 Mutations Accelerate NRAS-Mutant Leukemia
    Carratt, Sarah A.
    Schonrock, Zachary
    Braun, Theodore
    Coblentz, Cody
    Foley, Amy
    Maxson, Julia E.
    BLOOD, 2019, 134
  • [34] Clinical significance of SETBP1 expression in breast cancer.
    Ando, Yuki
    Masuda, Takaaki
    Hayashi, Naoki
    Mochizuki, Kenichi
    Abe, Tadashi
    Saito, Hideyuki
    Ozato, Yuki
    Nakano, Takafumi
    Koike, Kensuke
    Motomura, Yushi
    Takahashi, Junichi
    Toshima, Takeo
    Hisamatsu, Yuichi
    Yonemura, Yusuke
    Mimori, Koshi
    CANCER SCIENCE, 2022, 113 : 741 - 741
  • [35] SETBP1 mutation analysis in 944 patients with MDS and AML
    Thol, F.
    Suchanek, K. J.
    Koenecke, C.
    Stadler, M.
    Platzbecker, U.
    Thiede, C.
    Schroeder, T.
    Kobbe, G.
    Kade, S.
    Loeffeld, P.
    Banihosseini, S.
    Bug, G.
    Ottmann, O.
    Hofmann, W-K
    Krauter, J.
    Kroeger, N.
    Ganser, A.
    Heuser, M.
    LEUKEMIA, 2013, 27 (10) : 2072 - 2075
  • [36] Novel SETBP1 mutation in a chinese family with intellectual disability
    Le Wang
    Xu-Dong Wang
    Bo Yang
    Xue-Meng Wang
    Yu-Qian Peng
    Hang-Jing Tan
    Hong-Mei Xiao
    BMC Medical Genomics, 16
  • [37] PREVALENCE AND CLINICAL CHARACTERISTICS OF SETBP1 MUTATIONS IN MYELOID DISORDERS
    Winkelmann, N.
    Reichert, J.
    Schaefer, V.
    Waldau, A.
    Rinke, J.
    Hochhaus, A.
    Ernst, T.
    HAEMATOLOGICA, 2015, 100 : 220 - 220
  • [38] Novel SETBP1 mutation in a chinese family with intellectual disability
    Wang, Le
    Wang, Xu-Dong
    Yang, Bo
    Wang, Xue-Meng
    Peng, Yu-Qian
    Tan, Hang-Jing
    Xiao, Hong-Mei
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [39] SETBP1 mutation analysis in 944 patients with MDS and AML
    F Thol
    K J Suchanek
    C Koenecke
    M Stadler
    U Platzbecker
    C Thiede
    T Schroeder
    G Kobbe
    S Kade
    P Löffeld
    S Banihosseini
    G Bug
    O Ottmann
    W-K Hofmann
    J Krauter
    N Kröger
    A Ganser
    M Heuser
    Leukemia, 2013, 27 : 2072 - 2075
  • [40] Pathologic and Molecular Spectrum of SETBP1 Mutations in Myeloid Neoplasms
    Larson, Daniel
    Chen, Dong
    Phuong Nguyen
    Oliveira, Jennifer
    Reichard, Kaaren
    Hoyer, James
    Mehta, Nikita
    Viswanatha, David
    He, Rong
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1329 - 1330